PANTOVER®
Tablet

 
 

COMPOSITION:
Each E/C tablet contains: Pantoprazole sodium sesquihydrate 45.1mg
corresponds to pantoprazole 40.0mg.

INDICATIONS:
- In combination with two appropriate antibiotics for the eradication of Helicobacter pylori in patients with peptic ulcers with the objective of reducing the recurrence of duodenal and gastric ulcers caused by this microorganism.
- Duodenal ulcer.
- Gastric ulcer.
- Moderate and severe reflux esophagitis.

DOSAGE & ADMINISTRATION:
For duodenal ulcer, gastric ulcer, and reflux esophagitis:
1 Pantover gastro-resistant tablet daily in most cases. In individual cases the dose may be doubled (increase to 2 gastro-resistant tablets Pantover daily) especially when there has been no response to other treatment.

PRESENTATION:
Pantover is available in the following pack size:
Pantover E/C tab-14 tablets.